Envista Holdings Corporation

(NYSE: NVST · $23.60 ▼ 1.5%) Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco pioneered wire-and-bracket orthodontics, Kerr has supported clinicians for over 135 years, and DEXIS helped advance CBCT imaging.

The company's Specialty Products & Technologies segment develops and manufactures dental implant systems, prosthetics, clear aligners, brackets and wires, and orthodontic and lab products. Its Equipment & Consumables segment makes digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista estimates that its portfolio covers about 90% of dentists' clinical needs for diagnosing, treating and preventing dental conditions.

Guided by a culture of customer centricity and continuous improvement through the Envista Business System, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. The company operates in more than 120 countries and has more than 12,000 employees worldwide. It also offers training and education programs for dental professionals. Learn more at www.envistaco.com.